Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2009 2
2012 2
2013 1
2014 3
2017 1
2018 3
2019 2
2020 1
2021 1
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Economic and healthcare resource utilization assessments of PET imaging in Coronary Artery Disease diagnosis: a systematic review and discussion of opportunities for future economic evaluations.
Ferko N, Priest S, Almuallem L, Walczyk Mooradally A, Wang D, Oliva Ramirez A, Szabo E, Cabra A. Ferko N, et al. Among authors: szabo e. J Med Econ. 2024 Jan-Dec;27(1):715-729. doi: 10.1080/13696998.2024.2345507. Epub 2024 May 6. J Med Econ. 2024. PMID: 38650543 Free article.
Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective.
Gauthier-Loiselle M, Michalopoulos SN, Cloutier M, Serra E, Bungay R, Szabo E, Guérin A. Gauthier-Loiselle M, et al. Among authors: szabo e. J Manag Care Spec Pharm. 2021 Dec;27(12):1703-1713. doi: 10.18553/jmcp.2021.27.12.1703. J Manag Care Spec Pharm. 2021. PMID: 34818094 Free PMC article.
Patient-Administered Biologic and Biosimilar Filgrastim May Offer More Affordable Options for Patients with Nonmyeloid Malignancies Receiving Chemotherapy in the United States: A Budget Impact Analysis from the Payer Perspective.
Trautman H, Szabo E, James E, Tang B. Trautman H, et al. Among authors: szabo e. J Manag Care Spec Pharm. 2019 Jan;25(1):94-101. doi: 10.18553/jmcp.2018.18094. Epub 2018 Aug 7. J Manag Care Spec Pharm. 2019. PMID: 30084301 Free PMC article.
20 results